4.10.22Segment

Podiatry

Podiatric medicine and surgery practices, diabetic foot care programs, and podiatry management organizations treating foot, ankle, and lower extremity conditions.

5
Verticals

Overview

Podiatry covers podiatric medicine and surgery practices, diabetic foot-care programs, and podiatry management organizations treating foot, ankle, and lower-extremity conditions. Demand is supported by the aging population, diabetes prevalence, and the high cost of diabetic foot complications.

It is a fragmented specialty seeing emerging MSO and PE consolidation, with ancillary services (imaging, surgery, durable medical equipment) and diabetic-care programs enhancing the economics. The federal data places it in its own physician-office category.

Market snapshot

Market size
~$5.4B
Growth
~3.0%CAGR (2017–22, nominal)
Companies
~6,639 firms
Firms by employee count

95.7% of firms have fewer than 20 employees: 6,351 micro-businesses, below most mandates.

The investable universe288 firms with 20+ employees
20–99
22277%
100–499
259%
500+
4114%

~6,600 small podiatry practices (96% under 20 staff), a steady ~3%/yr aging-and-diabetes-driven specialty. A late-cycle roll-up target — PE-backed podiatry platforms are assembling the fragmented base, though only 41 firms exceed 500 employees.

NAICS 621391. U.S. Census Bureau — 2022 Statistics of U.S. Businesses; U.S. Census Bureau — 2022 Economic Census.

Business model & economics

Revenue model

Visit and procedure reimbursement plus ancillaries

Key economics

Revenue per firm
$808,376
Revenue per employee
$144,857
Employees per firm
5.5
Recurring revenue
Moderate

recurring diabetic and chronic foot care

EBITDA margin
15–25%
Capex intensity
Low

Characteristics

  • Balanced cost base — payroll is 35% of revenue, leaving room to scale margin without cutting staff
  • Moderate strategic-buyer pool — 41 firms exceed 500 employees; a scaled asset has buyers, but not many
  • Aging and diabetes prevalence drive demand.
  • Ancillaries and diabetic-care programs enhance economics.
  • Emerging MSO/PE consolidation.

NAICS 621391. U.S. Census Bureau — 2022 Statistics of U.S. Businesses; U.S. Census Bureau — 2022 Economic Census.

Geographic concentration

AlabamaAlaskaArizonaColoradoFloridaGeorgiaIndianaKansasMaineMassachusettsMinnesotaNorth CarolinaNorth DakotaOklahomaSouth DakotaTexasWyomingMissouriWest VirginiaIllinoisNew MexicoArkansasCaliforniaDelawareDistrict of ColumbiaHawaiiIowaKentuckyMarylandMichiganMississippiMontanaNew HampshireOhioOregonTennesseeUtahVirginiaWashingtonWisconsinNebraskaSouth CarolinaIdahoNevadaVermontLouisianaRhode IslandNew JerseyPennsylvaniaConnecticutNew York

Podiatry practices concentrate in the dense Northeast corridor — New Jersey, New York, Pennsylvania, and Connecticut — tracking population age and physician density.

New JerseyNew YorkPennsylvaniaConnecticut

U.S. Census Bureau — 2022 Statistics of U.S. Businesses (firms by state), NAICS 621391. Concentration shown by location quotient.

M&A deal context

Deal activityModerate

Who’s acquiring

  • Podiatry MSO platforms
  • PE-backed consolidators
  • Multispecialty groups

What’s driving deals

  • Emerging podiatry roll-up.
  • Diabetes and aging-driven demand.
  • Ancillary-driven economics.

Verticals in this segment

Find Podiatry acquisition targets

Search Acquisera’s index for companies classified under Podiatry (4.10.22) and build a targeted deal pipeline.

Search companies